Show simple item record

dc.contributor.authorWalsh, S
dc.contributor.authorPrichard, R
dc.contributor.authorHill, A D K
dc.date.accessioned2012-02-01T10:05:15Z
dc.date.available2012-02-01T10:05:15Z
dc.date.issued2012-02-01T10:05:15Z
dc.identifier.citationSurgeon. 2012 Feb;10(1):53-8. Epub 2011 Sep 9.en_GB
dc.identifier.issn1479-666X (Print)en_GB
dc.identifier.issn1479-666X (Linking)en_GB
dc.identifier.pmid22233555en_GB
dc.identifier.doi10.1016/j.surge.2011.08.004en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207341
dc.description.abstractThyroid carcinoma is the most commonly diagnosed endocrine malignancy. Its incidence is currently rising worldwide. The discovery of genetic mutations associated with the development of thyroid cancer, such as BRAF and RET, has lead to the development of new drugs which target the pathways which they influence. Despite recent advances, the prognosis of anaplastic thyroid carcinoma is still unfavourable. In this review we look at emerging novel therapies for the treatment of well-differentiated and medullary thyroid carcinoma, and advances and future directions in the management of anaplastic thyroid carcinoma.
dc.language.isoengen_GB
dc.titleEmerging therapies for thyroid carcinoma.en_GB
dc.contributor.departmentDepartment of Surgery, RCSI Smurfitt Building, Beaumont Hospital, Dublin 9,, Ireland.en_GB
dc.identifier.journalThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Irelanden_GB
dc.description.provinceLeinster
html.description.abstractThyroid carcinoma is the most commonly diagnosed endocrine malignancy. Its incidence is currently rising worldwide. The discovery of genetic mutations associated with the development of thyroid cancer, such as BRAF and RET, has lead to the development of new drugs which target the pathways which they influence. Despite recent advances, the prognosis of anaplastic thyroid carcinoma is still unfavourable. In this review we look at emerging novel therapies for the treatment of well-differentiated and medullary thyroid carcinoma, and advances and future directions in the management of anaplastic thyroid carcinoma.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record